Proteolysis targeting chimera therapy (JD Biosceinces)

N/A

Report date: 2023/10/09 10:20:28
NME

Base Information

Drug NameProteolysis targeting chimera therapy (JD Biosceinces)
Drug Alias NameGM-PROTAC (JD Biosciences)GM-PROTAC
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysis
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJD Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesJD Bioscience Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A